Chronic pain management in cats requires multimodal approaches combining multiple treatment modalities. Advanced protocols significantly improve quality of life for cats with osteoarthritis, dental disease, and other chronic conditions.
Feline chronic pain management has been transformed by the development of anti-NGF antibody therapies specifically designed for cats. These monthly injections target a key pain signaling molecule, providing sustained relief without the metabolic concerns associated with long-term NSAID use in cats with concurrent kidney disease. The multimodal approach — combining medication, weight management, physical environment modification, and nutraceutical support — produces better welfare outcomes than any single intervention because it addresses multiple mechanisms of chronic pain simultaneously. The challenge is convincing owners of the need for ongoing pain management when their cat's stoic nature makes pain invisible. The behavioral improvement seen in cats who receive appropriate chronic pain management — increased mobility, improved grooming, more social engagement, better appetite — demonstrates just how significant the welfare impact of untreated chronic pain is.